Low‐pH‐sensitive poly(ethylene glycol) (PEG)‐stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Gene Medicine

• Publication date

  2005-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jgm.634PMID 15515149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved preparation of PEG-diortho ester-diacyl glycerol conjugates.

  2004cited by this paper
• Chemical approaches to triggerable lipid vesicles for drug and gene delivery.

  2003cited by this paper
• Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization.

  2003cited by this paper
• Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid.

  2003cited by this paper
• Structural Basis of Protein-bound Endogenous Aldehydes

  2003cited by this paper
• Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*

  2003cited by this paper
• Targeting tumors with non-viral gene delivery systems.

  2002cited by this paper
• Gene Therapy Progress and Prospects: Nonviral vectors

  2002cited by this paper
• Tumor Regression by Targeted Gene Delivery to the Neovasculature

  2002cited by this paper
• Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate.

  2001cited by this paper
• Viral escape mechanisms – escapology taught by viruses

  2001cited by this paper
• Stabilized plasmid-lipid particles for systemic gene therapy.

  2000cited by this paper
• Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.

  2000influential reference
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery.

  2000cited by this paper
• Stabilized plasmid-lipid particles: construction and characterization

  1999cited by this paper
• Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

  1999cited by this paper
• Effect of PEG-lipid conjugates on the phase behavior of phosphatidylethanolamine dispersions

  1999cited by this paper
• Gene transfer with lipospermines and polyethylenimines.

  1998cited by this paper
• Self-Assembling DNA-Lipid Particles for Gene Transfer

  1997cited by this paper
• The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

  1997cited by this paper
• Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.

  1997cited by this paper
• Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery

  1996cited by this paper
• Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection.

  1996cited by this paper
• Formation of stable cationic lipid/DNA complexes for gene transfer.

  1996cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture

  1990cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.

  1987cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Use of n-octyl-beta-D-thioglucoside, a new nonionic detergent, for solubilization and reconstitution of membrane proteins.

  1984cited by this paper
• pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact.

  1984cited by this paper

• Synthesis and Biological Evaluation of Herceptin-Conjugated Liposomes Loaded with Lipocalin-2 siRNA for the Treatment of Inflammatory Breast Cancer

  2025cites this paper
• Nanohybrid cerasomes: Advancements in targeted drug and gene delivery

  2024cites this paper
• A Perspective of Engineered Lipids and Liposomes: Chemical Design and Functional Application Based on Therapeutic Safety

  2023cites this paper
• Non-viral nucleic acid delivery approach: A boon for state-of-the-art gene delivery

  2023cites this paper
• Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape

  2023cites this paper
• PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective

  2023cites this paper
• Comparison of different types of liposomal nano structures for microRNA transfection to human mesenchymal stem cell line S1939

  2022cites this paper
• Nanodelivery of nucleic acids

  2022cites this paper
• Overview of polyethylene glycol-based materials with a special focus on core-shell particles for drug delivery application.

  2021cites this paper
• PolymericsiRNA gene delivery- transfection efficiency versus cytotoxicity.

  2019cites this paper
• Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastases.

  2019cites this paper
• Liposomal delivery of CRISPR/Cas9

  2019cites this paper
• Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9

  2019cites this paper
• A Multifunctional Envelope-Type Nano Device for Cancer Therapy

  2019cites this paper
• DePEGylation strategies to increase cancer nanomedicine efficacy.

  2019cites this paper
• Reassessment of long circulation via monitoring of integral polymeric nanoparticles justifies a more accurate understanding.

  2018cites this paper
• Development of a novel cationic liposome: Evaluation of liposome mediated transfection and anti-proliferative effects of miR-101 in acute myeloid leukemia

  2018cites this paper
• Dynamically PEGylated and Borate-Coordination-Polymer-Coated Polydopamine Nanoparticles for Synergetic Tumor-Targeted, Chemo-Photothermal Combination Therapy.

  2018cites this paper
• Ring-opening polymerization of diepoxides as an alternative method to overcome PEG dilemma in gene delivery

  2018cites this paper
• Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration☆

  2017cites this paper
• Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo

  2017cites this paper
• Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics.

  2017cites this paper
• Nanoparticles as nucleic acid delivery vectors

  2017cites this paper
• Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.

  2017cites this paper
• Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery.

  2016cites this paper
• pH-Sensitive Nanosystems

  2016cites this paper
• The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.

  2016cites this paper
• Self-assembly of size-controlled liposomes on DNA nanotemplates

  2016cites this paper
• Cationic Lipid-Based Nucleic Acid Vectors.

  2016cites this paper
• Intracellular Delivery of Proteins and Peptides

  2016cites this paper
• Enhanced gene delivery to the lung using biodegradable polyunsaturated cationic phosphatidylcholine-detergent conjugates.

  2016cites this paper
• Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery.

  2015cites this paper
• Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer

  2015cites this paper
• Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA

  2015cites this paper
• Ligand-Appended Liposomes: Targeted Breast Cancer Therapy

  2015cites this paper
• Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization and cellular uptake

  2015cites this paper
• Exploring New Peg-Dendritic Block Copolymers as Sirna Delivery Vectors

  2015cites this paper
• Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.

  2015cites this paper
• Long-Circulating Therapies for Cancer Treatment

  2015cites this paper
• Stimuli-Sensitive Liposomes: Lipids as Gateways for Cargo Release

  2015cites this paper
• Nanolipoparticles-mediated MDR 1 siRNA delivery : preparation , characterization and cellular uptake

  2014influential citation
• Nanomedicine for Cancer Treatment

  2014cites this paper
• A bioresponsive polymeric implant for site-specific prolonged drug delivery

  2014cites this paper
• Bandage-Based Wearable Potentiometric Sensor for Monitoring Wound pH

  2014cites this paper
• Passive vs. Active Targeting: An Update of the EPR Role in Drug Delivery to Tumors

  2014cites this paper
• Effective Nanoparticle‐based Gene Delivery by a Protease Triggered Charge Switch

  2014cites this paper
• Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.

  2014cites this paper
• Characterization and compatibility of hydroxyethyl starch–polyethylenimine copolymers for DNA delivery

  2014cites this paper
• Lipid-coated calcium phosphate nanoparticles for nonviral gene therapy.

  2014cites this paper
• Bionanocomposites Assembled by “From Bottom to Top” Method

  2014cites this paper
• Technologies for Investigating the Physiological Barriers to Efficient Lipid Nanoparticle–siRNA Delivery

  2013cites this paper
• Down‐regulated lysosomal processing improved pegylated lipopolyplex‐mediated gene transfection

  2013cites this paper
• The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors.

  2013cites this paper
• The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes.

  2013cites this paper
• Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors

  2013cites this paper
• How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.

  2013cites this paper
• Controlled drug-release system based on pH-sensitive chloride-triggerable liposomes

  2013cites this paper
• Lipid Nanoparticles for the Delivery of Nucleic Acids

  2013cites this paper
• Genome-Wide RNA Interference Screening

  2013cites this paper
• pH-Responsive Polymers for Delivery of Nucleic Acid Therapeutics

  2013cites this paper
• Polymeric biomaterials with engineered degradation

  2013cites this paper
• A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for “smart” small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells

  2013cites this paper
• Magnetic nanoparticles for MRI of brain tumors.

  2012cites this paper
• Accurate Methodology for Monitoring Biomembrane Events

  2012cites this paper
• Light-regulated host-guest interaction as a new strategy for intracellular PEG-detachable polyplexes to facilitate nuclear entry.

  2012cites this paper
• Challenges in Development of Targeted Liposomal Therapeutics

  2012cites this paper
• DNA Nanoparticles for Non-viral Gene Therapy: Mechanistic Studies and Targeting

  2012cites this paper
• Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid.

  2012cites this paper
• siRNA delivery with lipid-based systems: promises and pitfalls.

  2012cites this paper
• Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery.

  2012cites this paper
• Gold Nanomaterials: Preparation, Chemical Modification, Biomedical Applications and Potential Risk Assessment

  2012cites this paper
• Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery.

  2012cites this paper
• Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.

  2012cites this paper
• Multicomponent synthetic polymers with viral-mimetic chemistry for nucleic acid delivery.

  2012cites this paper
• pH-sensitive siRNA delivery systems

  2012cites this paper
• Delivery Strategies for RNAi to the Nervous System

  2011cites this paper
• The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

  2011cites this paper
• Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding.

  2011cites this paper
• Toxicogenomics of Nonviral Cationic Gene Delivery Nanosystems

  2011cites this paper
• A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.

  2011cites this paper
• Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy

  2011cites this paper
• Challenges and Opportunities in Gene Delivery

  2011cites this paper
• Nanoparticles for Nucleic Acid Delivery

  2011cites this paper
• Delivery of Nucleic Acids and Gene Delivery

  2011cites this paper
• Invading target cells: multifunctional polymer conjugates as therapeutic nucleic acid carriers

  2011cites this paper
• Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

  2011cites this paper
• Modification of Bcl-x and Mcl-1 pre-mRNA splicing using splice-switching oligonucleotides

  2011cites this paper
• A DNA microarray-based analysis of the host response to a nonviral gene carrier: a strategy for improving the immune response.

  2011cites this paper
• Knocking down barriers: advances in siRNA delivery

  2010cites this paper
• Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes.

  2010cites this paper
• "HFP" fluorinated cationic lipids for enhanced lipoplex stability and gene delivery.

  2010cites this paper
• Cationic lipid-mediated nucleic acid delivery: beyond being cationic.

  2010cites this paper
• Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.

  2010cites this paper
• Liposomes as ‘smart’ pharmaceutical nanocarriers

  2010cites this paper
• Transfection efficiency of lipoplexes for site-directed delivery

  2010cites this paper
• Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection.

  2009cites this paper
• Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease.

  2009cites this paper
• Dynamic endosomolytic polymer conjugates for pDNA and siRNA delivery

  2009cites this paper
• Regulation of gene expression for therapy of age related macular degeneration

  2009cites this paper
• Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell.

  2009cites this paper